FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026868476> ?p ?o ?g. }

• W2026868476 endingPage "5319" @default.
• W2026868476 startingPage "5311" @default.
• W2026868476 abstract "The Towne, human cytomegalovirus (CMV) vaccine is safe and immunogenic but has not prevented infection at doses tested to date. We administered 3000 pfu Towne CMV vaccine, with or without adjuvant recombinant interleukin-12 (rhIL-12), to CMV-seronegative healthy volunteers and then measured CMV gB-specific IgG titers and CMV-specific CD4+ and CD8+ T cell proliferation and IFNgamma expression after stimulation with whole viral lysate and immunodominant peptide CMV antigens. Adjuvant rhIL-12 at doses up to 2 microg were well-tolerated and associated with (1) dose-related increases in peak anti-CMV gB IgG titers (though not in sustained titers), (2) dose-related increases in the weak CMV viral lysate-specific CD4+ T cell proliferation responses induced by vaccine alone after 360 days of follow-up, and (3) decreases in the very robust CMV IE-specific peak CD4+ T cell and Day 360 CD8+ T cell proliferation responses induced by the vaccine alone. Also, qualitative CD8+ T cell IFNgamma responses to stimulation with the immunodominant CMV antigen, pp65, tended to occur more frequently in vaccinees who received 0.5-2.0 microg rhIL-12 compared to lower dose or no rhIL-12. Thus, adjuvant IL-12 may be a promising strategy for improving antibody and T cell immune responses to a CMV vaccine." @default.
• W2026868476 created "2016-06-24" @default.
• W2026868476 creator A5002830154 @default.
• W2026868476 creator A5011076506 @default.
• W2026868476 creator A5011223721 @default.
• W2026868476 creator A5011456144 @default.
• W2026868476 creator A5014245136 @default.
• W2026868476 creator A5031378595 @default.
• W2026868476 creator A5043581803 @default.
• W2026868476 creator A5049249045 @default.
• W2026868476 creator A5055682804 @default.
• W2026868476 creator A5077540938 @default.
• W2026868476 creator A5082788063 @default.
• W2026868476 date "2006-06-01" @default.
• W2026868476 modified "2023-09-27" @default.
• W2026868476 title "Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12" @default.
• W2026868476 cites W1517765711 @default.
• W2026868476 cites W1698869900 @default.
• W2026868476 cites W1965046421 @default.
• W2026868476 cites W1971842136 @default.
• W2026868476 cites W1989550920 @default.
• W2026868476 cites W1990720163 @default.
• W2026868476 cites W1992047047 @default.
• W2026868476 cites W1994667326 @default.
• W2026868476 cites W2003150496 @default.
• W2026868476 cites W2013769140 @default.
• W2026868476 cites W2015400860 @default.
• W2026868476 cites W2021106326 @default.
• W2026868476 cites W2031675084 @default.
• W2026868476 cites W2053161235 @default.
• W2026868476 cites W2053901884 @default.
• W2026868476 cites W2056164673 @default.
• W2026868476 cites W2061517625 @default.
• W2026868476 cites W2066964567 @default.
• W2026868476 cites W2079647175 @default.
• W2026868476 cites W2090851364 @default.
• W2026868476 cites W2091978710 @default.
• W2026868476 cites W2093475848 @default.
• W2026868476 cites W2102254194 @default.
• W2026868476 cites W2103589467 @default.
• W2026868476 cites W2132337999 @default.
• W2026868476 cites W2132603771 @default.
• W2026868476 cites W2144967699 @default.
• W2026868476 cites W2165012523 @default.
• W2026868476 cites W2168744744 @default.
• W2026868476 cites W2169090314 @default.
• W2026868476 cites W2191608347 @default.
• W2026868476 cites W2269774696 @default.
• W2026868476 cites W2409312602 @default.
• W2026868476 cites W4242937856 @default.
• W2026868476 doi "https://doi.org/10.1016/j.vaccine.2006.04.017" @default.
• W2026868476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16701925" @default.
• W2026868476 hasPublicationYear "2006" @default.
• W2026868476 type Work @default.
• W2026868476 sameAs 2026868476 @default.
• W2026868476 citedByCount "52" @default.
• W2026868476 countsByYear W20268684762012 @default.
• W2026868476 countsByYear W20268684762013 @default.
• W2026868476 countsByYear W20268684762014 @default.
• W2026868476 countsByYear W20268684762015 @default.
• W2026868476 countsByYear W20268684762016 @default.
• W2026868476 countsByYear W20268684762017 @default.
• W2026868476 countsByYear W20268684762018 @default.
• W2026868476 countsByYear W20268684762020 @default.
• W2026868476 countsByYear W20268684762021 @default.
• W2026868476 countsByYear W20268684762022 @default.
• W2026868476 countsByYear W20268684762023 @default.
• W2026868476 crossrefType "journal-article" @default.
• W2026868476 hasAuthorship W2026868476A5002830154 @default.
• W2026868476 hasAuthorship W2026868476A5011076506 @default.
• W2026868476 hasAuthorship W2026868476A5011223721 @default.
• W2026868476 hasAuthorship W2026868476A5011456144 @default.
• W2026868476 hasAuthorship W2026868476A5014245136 @default.
• W2026868476 hasAuthorship W2026868476A5031378595 @default.
• W2026868476 hasAuthorship W2026868476A5043581803 @default.
• W2026868476 hasAuthorship W2026868476A5049249045 @default.
• W2026868476 hasAuthorship W2026868476A5055682804 @default.
• W2026868476 hasAuthorship W2026868476A5077540938 @default.
• W2026868476 hasAuthorship W2026868476A5082788063 @default.
• W2026868476 hasConcept C147483822 @default.
• W2026868476 hasConcept C159047783 @default.
• W2026868476 hasConcept C159654299 @default.
• W2026868476 hasConcept C167672396 @default.
• W2026868476 hasConcept C203014093 @default.
• W2026868476 hasConcept C2776090121 @default.
• W2026868476 hasConcept C2777863537 @default.
• W2026868476 hasConcept C2780868878 @default.
• W2026868476 hasConcept C3017875465 @default.
• W2026868476 hasConcept C32611913 @default.
• W2026868476 hasConcept C71924100 @default.
• W2026868476 hasConcept C86803240 @default.
• W2026868476 hasConcept C8891405 @default.
• W2026868476 hasConceptScore W2026868476C147483822 @default.
• W2026868476 hasConceptScore W2026868476C159047783 @default.
• W2026868476 hasConceptScore W2026868476C159654299 @default.
• W2026868476 hasConceptScore W2026868476C167672396 @default.
• W2026868476 hasConceptScore W2026868476C203014093 @default.
• W2026868476 hasConceptScore W2026868476C2776090121 @default.

• next